Who owns COEPTIS THERAPEUTICS HLDGS I?
- Ticker: COEP
- CUSIP Number: 19207a207
Tip: Access positions for across all investors
Analyze quarterly positions in Coeptis Therapeutics Hldgs I with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Coeptis Therapeutics Hldgs I stock
Who bought or sold COEPTIS THERAPEUTICS HLDGS I this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Group | 51k | $885k | 84% | Sep 2025 |
|
| Geode Capital Management | 37k | $653k | 84% | Sep 2025 |
|
| State Street Corporation | 20k | $347k | 100% | Sep 2025 |
|
| Renaissance Technologies | 19k | $323k | 100% | Sep 2025 |
|
| Yorkville Advisors Global | 8.0k | $140k | -85% | Sep 2025 |
|
| Steward Partners Investment Advisory | 2.5k | $44k | 150% | Sep 2025 |
|
| Pnc Financial Services | 463.00 | $8.1k | 100% | Sep 2025 |
|
| Barclays | 3.00 | $51.999900 | 0% | Sep 2025 |
|
Who sold out of Coeptis Therapeutics Hldgs I?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Tower Research Capital | Jun 2025 | 268.00 | $2.1k |
| UBS Group | Jun 2025 | 82.00 | $640.001800 |
| Semmax Financial Advisors | Mar 2025 | 5.00 | $48.000000 |